 "NCLT initiates insolvency proceedings against Orchid Pharma")
The company, in a regulatory filing, said that the order issued by the Chennai bench, admitting the petition filed by an operational creditor Lakshmi Vilas Bank Ltd, initiates corporate insolvency resolution process (CIRP) against the pharmaceutical firm.
The company is in the process of exploring a suitable legal recourse, including preferring an appeal before the NCLT following consultations with its legal counsel.
Orchid Pharma, once a leader in injectables and some of the Active Pharmaceutical Ingredients (API) manufacturing, has been suffering from a financial crisis for a number of years now and its investors and lenders have approached various legal forums in their lookout for a remedy.
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app